Announced Tue, 19 May · 23:26 IST

Healthcare Global Enterprises Limited has informed the Exchange regarding Appointment of Mr Ravi Gothwal as AVP Investor Relations, designated as Senior Management Personnel of the company w.e.f. May 19, 2026.

Management Changes View source PDF

HCG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.7%1-day move
₹649.50
prior close
₹632.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.3+3.4+3.4+2.9-2.7+0.9+1.3+1.0+1.6-0.5-3.5-5.4+0.9
Up moveDown movePending
AI summary

HCG Limited's Board of Directors approved multiple leadership changes at its meeting on May 19, 2026. Key appointments include: (1) Mr. Sanjeev Kumar as new CFO and KMP effective May 25, 2026, replacing Dr. Manish Mattoo who served as interim CFO; (2) Mr. Ravi Gothwal appointed as AVP - Investor Relations (Senior Management Personnel) effective May 19, 2026, bringing 13 years of experience including prior IR role at Medanta; (3) Mr. Rajiv Maliwal re-appointed as Non-Executive Independent Director for a second 5-year term starting May 25, 2026, subject to shareholder approval; and (4) Mr. Vijay S. Shanbhag re-appointed as Internal Auditor for one year from May 30, 2026.

Likely market impact

The appointment of a dedicated CFO with 30+ years of experience across telecom, hospitality, and healthcare sectors, including leading Medanta's IPO, signals improved financial leadership and investor communication capability. The addition of a specialized IR head strengthens shareholder engagement.